Cancer survivors face psychosocial issues that increase their risk of suicide. This study examined the risk of suicide across cancer sites, with a focus on survivors of head and neck cancer (HNC). METHODS: The Surveillance, Epidemiology, and End Results 18-registry database (from 2000 to 2014) was queried for the top 20 cancer sites in the database, including HNC. The outcome of interest was suicide as a cause of death. The mortality rate from suicide was estimated for HNC sites and was compared with rates for 19 other cancer sites that were included in the study. Poisson regression was used to estimate adjusted rate ratios (aRRs) and 95% confidence intervals (CIs) for 1) HNC versus non-HNC sites (the other 19 cancer sites combined), and 2) HNC versus each individual cancer site. Models were stratified by sex, controlling for race, marital status, age, year, and stage at diagnosis. RESULTS: There were 404 suicides among 151,167 HNC survivors from 2000 to 2014, yielding a suicide rate of 63.4 suicides per 100,000 person-years. In this timeframe, there were 4493 suicides observed among 4219,097 cancer survivors in the study sample, yielding an incidence rate of 23.6 suicides per 100,000 person-years. Compared with survivors of other cancers, survivors of HNC were almost 2 times more likely to die from suicide (aRR, 1.97; 95% CI, 1.77-2.19). There was a 27% increase in the risk of suicide among HNC survivors during the period from 2010 to 2014 (aRR, 1.27; 95% CI, 1.16-1.38) compared with the period from 2000 to 2004. CONCLUSIONS: Although survival rates in cancer have improved because of improved treatments, the risk of death by suicide remains a problem for cancer survivors, particularly those with HNC. Cancer 2018;124:4072-4079.
INTRODUCTION
An estimated 1.7 million new cases of cancer were diagnosed in 2017. 1 Concomitant with the increasing cancer incidence have been improved treatment options and increasing numbers of cancer survivors. 2 Currently, more than 15.5 million individuals are living with a cancer diagnosis, and the number of cancer survivors is projected to be more than 20 million in 2026. 3 Among the more than 15 million cancer survivors in the United States, at least 430,000, or 3%, are survivors of head and neck cancer (HNC). 4 Similar to the general United States cancer population, the number of HNC survivors has increased in the last 3 decades. 4 However, survivorship comes at a cost for many of these survivors. Postdiagnosis, they face persistent and late effects of their diagnosis and treatment, such as functional and esthetic compromise; [5] [6] [7] [8] however, these effects are often overshadowed by the need to be cured or to survive. 9 In the presence of lifestyle-related comorbidities and competing causes of death, these persistent and late effects may increase psychosocial morbidity, such as depression, psychological distress, fear of cancer recurrence, and suicidal ideation. [10] [11] [12] [13] [14] [15] Suicide rates have increased in the United States population since 1999, 16 yet the suicide rate is greater among cancer survivors than among survivors of other chronic diseases and the general population. 5, 17 It is expected that this varies across cancer sites based on various emotional trauma and psychosocial issues associated with cancer sites. 18, 19 A few studies have described suicide rates or have compared suicide risks across cancer sites, but some are based on older samples of patients with cancer, before the recent increase in deaths of despair (such as suicide) in the general population from 1999 to 2014. 20 Results also
Cancer October 15, 2018 have been inconsistent because of small sample sizes, methodology, or study bias. 13, 21 Some studies have described suicide in cancer survivors based on single anatomic sites, such as HNC, 7 pancreatic cancer, 22 or gastric cancer. 23 Other studies have described suicide in cancer survivors based on physiological systems or regions, such as genitourinary 24 or gynecologic. 25 Among the studies from the United States that have described suicide among HNC survivors, a consistent finding has been that there is an increased risk of suicide among this population and that HNC is among the top 4 cancer sites associated with suicide. [5] [6] [7] 13, 18, 26 However, only 2 previous studies have described the problem of suicide across more than a dozen cancer sites, both of which were published at least a decade ago. 5, 6 The objectives of the current study were: 1) to examine mortality rates from suicide among survivors of HNC and other top cancer sites and 2) to compare the risk of suicide among HNC survivors with the risk among survivors of other cancers.
MATERIALS AND METHODS

Data Source and Study Population
Survivors were identified from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) 18-registry database using cancers diagnosed during 2000 through 2014. 27 SEER is a publicly available, nationally representative, population-based cancer database that contains more than 8 million cancer cases, with data that span 4 decades and cover 28% of the United States population. It is considered a valid source of cancer incidence and survival data in the United States. 28 In addition, SEER has developed and maintained high-quality, validated data on causes of death among cancer survivors, providing insight into relative and cause-specific deaths in this population. 29, 30 Our study was determined exempt by the St. Louis University Institutional Review Board, because publicly available de-identified data were used. Data were retrieved using SEER*Stat 8.3.4 (Surveillance Research Program, National Cancer Institute, Bethesda, MD). Data for adult patients (aged ≥20 years) who had a first primary malignancy of the head and neck were included. Because most HNCs are squamous cell carcinomas, we included only squamous cell carcinoma in the following anatomic sites: oral cavity and pharynx, larynx, nasal cavity, and sinuses. 31 Although a previous study on HNC suicide included thyroid cancer, 7 we excluded those cases from HNC, because thyroid cancer, although situated in the head and neck region, is an endocrine cancer and is morphologically, histologically, and pathologically different from squamous cell carcinoma of the head and neck. 31, 32 For comparison, the following non-HNC sites were included in the study: prostate; breast; lung and bronchus; colon and rectum; urinary bladder; melanoma of the skin; non-Hodgkin lymphoma; kidney and renal pelvis; corpus and uterus, not otherwise specified; leukemia; pancreas; thyroid; stomach; liver and intrahepatic bile duct; Hodgkin lymphoma; brain and other nervous system; testis; ovary; and cervix uteri.
Outcome of Interest
The outcome of interest was suicide as a cause of death among patients with HNC. Similar to other studies, suicide as cause of death was identified from International Classification of Diseases (ICD) (versions 9 and 10) cause-of-death codes in SEER (suicide and self-inflicted injury; ICD-9 codes 950-959; ICD-10 codes, U03, X60-X84, and Y87.0; recode 50220).
33
Primary Independent Variables
Cancer site was grouped in 2 ways. First, site was dichotomized as HNC (as previously defined) and contrasted with all other cancer sites combined. Second, suicide risk was compared across all 20 individual cancer sites, with HNC as the reference.
Covariates
On the basis of the cancer suicide and survivorship literature, 5, 6, 11, 12 covariates included sex (male, female), year of diagnosis (2000-2004, 2005-2009, 2010-2014) , marital status at diagnosis (never married, married/partnered, previously married [divorced, separated, widowed]), race (white, black, other), age (20-39, 40-59, 60-69, ≥70 years), and stage (localized, regional, distant, unknown/unstaged).
Statistical Analysis
Bivariate associations between the outcome of interest (committed suicide vs did not commit suicide) with cancer site and other covariates were examined using chisquare tests. The suicide rate for each cancer site was calculated per 100,000 person-years. To estimate the suicide rate in the general US population in reference to our cancer population, we calculated rates based on US Census Bureau mortality data linked to SEER*Stat. 34 Multivariate Poisson regression models were used to determine whether site (both dichotomous site and individual site) was associated with suicide while controlling for covariates, yielding adjusted rate ratios (aRRs). 35 Because some cancer sites are sex-specific, the models with individual cancer sites were stratified by sex. SAS System for Windows (version 9.4; SAS Institute Inc, Cary, NC) was
Cancer October 15, 2018 used for all analyses. All statistical tests were 2-sided, with P values <.05 considered statistically significant.
RESULTS
Demographic and Sample Characteristics
We examined the SEER data for 4219,097 cancer survivors. Of those, 151,167 were diagnosed with HNC. Between 2000 and 2014, 404 suicides were recorded for HNC survivors, yielding a rate of 63.4 suicides per 100,000 person-years (see Table 1 ). For the entire study population, 4493 suicides were observed, for a mortality rate of 23.6 suicides per 100,000 person-years. The suicide rate we calculated for the general US population was 17.4 per 100,000 person-years. Only pancreatic cancer survivors had a higher suicide rate than HNC survivors at 86.4 suicides per 100,000 person-years. 
Demographic and Clinical Factors and Risk for Suicide
HNC Versus Individual Cancer Types
Among male cancer survivors (Fig. 1) , HNC survivors had an increased risk of suicide compared with survivors of colorectal cancer, Hodgkin and non-Hodgkin lymphoma, kidney cancer, leukemia, liver cancer, melanoma, prostate cancer, testis cancer, thyroid cancer, and bladder cancer. Only pancreatic cancer survivors had a significantly higher risk of suicide than HNC survivors (aRR, 1.53).
For female cancer survivors (Fig. 2) , HNC survivors had an increased risk of suicide compared with survivors of melanoma, Hodgkin and non-Hodgkin lymphoma, leukemia, uterine cancer, breast cancer, thyroid cancer, colorectal cancer, kidney cancer, and brain cancer.
DISCUSSION Although several studies have described an increased risk of suicide in the cancer survivor population, to our knowledge, our study is the first to compare the suicide risk in HNC survivors versus survivors of other leading cancers as a group. The results demonstrate a significantly increased risk of suicide among survivors of HNC. Cancer October 15, 2018 Two head and neck sites (oral cavity and pharynx) have previously been reported to contribute 20% of the total suicide burden among male cancer survivors. 18 Results from the current study are similar to the study by Kendal, 6 who reported that the risk of suicide increased significantly among HNC survivors relative to survivors of other cancers, similar to what we observed among male survivors. However, Kendal did not calculate the suicide rate per 100,000 person-years for HNC sites, which limits our ability to compare both studies objectively. In addition, there was very little overlap in the years of study between the report by Kendal 6 and our current study (1973-2001 vs 2000-2014, respectively) . This difference in years of study also was true for Misono Cancer October 15, 2018 and colleagues, 5 who followed cancer survivors between 1973 and 2002. The current study also differs from that of Misono et al 5 in that they compared results with the general US population, whereas we compared our results with the cancer population in the SEER database. Only survivors with pancreatic cancer had a significantly higher risk of suicide than HNC survivors in the current study, whereas Misono et al reported higher suicide rates among survivors of lung/bronchus and stomach cancers than among HNC survivors. 5 Those authors also separated larynx cancer from other head and neck sites, whereas we grouped oral cavity, pharynx, and larynx altogether as HNC. In addition, Misono et al 5 only used standard mortality ratios (SMRs) to compare mortality rates, whereas we performed Poisson regression analysis that adjusted for more covariates. Kam and colleagues 7 had more years of overlap with our study (1973-2011 vs 2000-2014, respectively); however, they included thyroid cancer. As shown both in their study and in the current report, the suicide rates for thyroid cancer survivors are lower compared with the general population and substantially lower compared with head and neck anatomic sites, such as oral cavity, oropharynx, larynx, hypopharynx, and nasopharynx. 7 Hence, the suicide rate they reported for HNC survivors was markedly lower than ours (37.9 of 100,000 person-years vs 63.4 of 100,000 person-years).
In the current study, suicide risk was elevated in survivors of HNC compared with survivors of other major cancers. To put this in context, we calculated the suicide rate in the general population using the Census Bureau data linked to SEER and produced a rate of 17.4 per 100,000 person-years, compared with 12.0 per 100,000 person-years approximately 1 decade earlier. 26 Although the suicide rate we calculated in our general cancer population was 23.6 per 100,000 person-years, by comparison, the rate was 63.4 per 100,000 person-years for HNC survivors, which was almost 4 times that for the general US population. In addition, we demonstrated a significant increase in the risk of HNC survivors dying from suicide in the last 5 years of our study (27% increased risk) compared with the period between 2000 and 2004. This corroborates a recent report from the Centers for Disease Control and Prevention that highlighted a 25% increase in the suicide rate in the general US States population since 1999. 36 It is important to understand the factors underlying this elevated risk of suicide among HNC survivors compared with other cancer survivors as well as the general population.
HNC survivors have unique treatment needs; the disease has been described as the most emotionally traumatic and psychologically distressing of all cancers. 18, 37 There are several important sources of distress unique to HNC survivors, including persistent and late effects of treatment, such as functional and esthetic compromise (eg, disfigurement and body image issues), swallowing difficulty, ototoxicity, and depression. 14, 15, [38] [39] [40] Pain issues and substance abuse are also more prevalent in this population, and both have been associated with an increased risk for suicide. 41, 42 Many HNC survivors face serious economic issues, including loss of employment and financial stress from medical expenses related to treatment. Approximately one-half of HNC survivors become functionally disabled and are unable to return to work after completing treatment. 43 In addition to financial strain from loss of employment, there are also significant costs associated with cancer treatment; a previous study described HNC as the most expensive cancer to treat. 44 Cancer is the leading cause of medical-related bankruptcy in the Cancer October 15, 2018 United States, 45 and a recent study documented bankruptcy as a risk factor for mortality patients who have cancer, with speculation that financial insolvency may limit access to treatment. 46 Financial downturn and bankruptcy are associated with both depression and suicide. 47, 48 More attention needs to be paid to these treatment-related, psychosocial and financial toxicity factors that increase the risk of suicide among HNC and other cancer survivors. 49, 50 
Strengths and Limitations
Like any analysis of existing data, there were some limitations of our study. First, depression status, which is a key risk factor for suicide, was not available. Second, we did not have any information on some risk factors for suicide, such as comorbid psychiatric conditions, family history of suicide, or substance abuse. Third, we did not assess treatment or medical late effects, functional status, pain, disfigurement, and other important quality-of-life variables, because these were not available in our data set. Fourth, because this was a retrospective study, no causal inferences could be made between cancer and suicide. Despite these limitations, the current study describes the risk of suicide for survivors of HNC and of 19 other cancer types. We used high-quality SEER data, covering over 4 million cancer survivors with a long follow-up period, making it one of the largest studies to date focused on suicide in a cancer population. Unlike previous studies that used SMRs, which only control for age, race, and sex, 5, 7 we adjusted for these and several other important clinical and nonclinical covariates using a Poisson regression model, and we reported true relative risks. In addition, rather than comparing suicide in the cancer population versus suicide in the general US population using SMRs, we compared HNC suicide rate versus suicides in other non-HNC sites.
Clinical and Public Health Implications
This study increases awareness about the problem of suicide among cancer survivors. The recent Moonshot Blue Ribbon Panel highlighted survivorship as an important area for future research 51 ; however, cancer research has been dominated by efforts to cure cancer. Recent initiatives mandating distress screening could facilitate the identification of distressed patients with cancer and the sources of their distress, including physical symptoms, financial difficulties, and emotional concerns. 52 , 53 Yet a recently published survey of distress screening adherence Cancer October 15, 2018 in 55 cancer centers indicated that less than two-thirds of patients were screened. 52, 54, 55 The psychosocial literature indicates that screening for psychological distress may be inadequate, 56 and it is particularly difficult to screen for a low-incidence outcome like suicide. 57 Furthermore, many physicians may not be comfortable discussing psychosocial issues like suicide with patients or their relatives. 58 Therefore, although there is a growing consensus around the importance of appropriate assessment and follow-up after a positive distress screen, 59,60 assessing risk for suicide will likely require more time than is available in a routine office visit. Screening should be viewed as a doorway to further communication, appropriate assessment, and tailored interventions, all of which are considered best practice in psychosocial care for survivors of HNC. 61 In conclusion, our study highlights suicide as an important issue for HNC survivors and cancer survivors in general. The need to understand this problem of cancer-associated suicide has become even more important as more patients live beyond their cancer diagnosis and treatment. Mitigating mortality from suicide will necessitate the development of evidence-based protocols for the assessment and treatment of suicide risks.
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